Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
Recruiting · NCT07235007 · Registry updated 2026-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Extrahepatic Cholangiocarcinoma, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Recruiting | Not applicable | 2026-01-13 | NCT07235007 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aichi Medical University | 2 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aichi Medical University | Aichi | Japan | 3 |
| Gangnam Severance Hospital, Yonsei University College of Medicine | Seoul | South Korea | 1 |
| Gifu University Hospital | Gifu | Japan | 8 |
| Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine | Seoul | South Korea | 3 |
| Nagoya City University Hospital | Aichi | Japan | 2 |
| Nagoya City University Midori Municipal Hospital | Aichi | Japan | 1 |
| Pusan National University Hospital | Busan | South Korea | 25 |
| Severance Hospital, Yonsei University College of Medicine | Seoul | South Korea | 3 |